UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003446
Receipt number R000004169
Scientific Title Genetic and molecular-biological study of hereditary coagulopathy
Date of disclosure of the study information 2010/07/01
Last modified on 2015/05/07 21:24:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Genetic and molecular-biological study of hereditary coagulopathy

Acronym

Study of hereditary coagulopathy

Scientific Title

Genetic and molecular-biological study of hereditary coagulopathy

Scientific Title:Acronym

Study of hereditary coagulopathy

Region

Japan


Condition

Condition

hereditary coagulopathy

Classification by specialty

Hematology and clinical oncology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To identify genetic and molecular biological abnormality in cases with hereditary coagulopathy

Basic objectives2

Others

Basic objectives -Others

Analysis of genetic disorder

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase



Assessment

Primary outcomes

Identification of genetic abnormality and molecular abnormality

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patinents who are suspected to suffer from hereditary coagulopathy.

Key exclusion criteria

Patients who do not agree with genetic analysis.

Target sample size

25


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shimpei Kasagi

Organization

Kobe University Hospital

Division name

Department of clinical laboratory

Zip code


Address

7-5-2, kusunoki-cho, chuo-ku,kobe,hyogo,japan

TEL

078-382-5111

Email

kobe470@med.kobe-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Seiji Kawano

Organization

Kobe University Hospital

Division name

Department of clinical laboratory

Zip code


Address

7-5-2, kusunoki-cho, chuo-ku,kobe,hyogo,japan

TEL

078-382-5111

Homepage URL

http://www.hosp.kobe-u.ac.jp/index.html

Email

sjkawano@med.kobe-u.ac.jp


Sponsor or person

Institute

Kobe University

Institute

Department

Personal name



Funding Source

Organization

Kobe University

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

神戸大学医学部付属病院(兵庫県)


Other administrative information

Date of disclosure of the study information

2010 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

Fifty cases were investigated for AT deficiency and PS deficiency.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2010 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2010 Year 06 Month 01 Day

Last follow-up date

2014 Year 03 Month 01 Day

Date of closure to data entry

2014 Year 03 Month 01 Day

Date trial data considered complete

2015 Year 03 Month 01 Day

Date analysis concluded

2015 Year 03 Month 01 Day


Other

Other related information

Fifty cases were investigated for AT deficiency and PS deficiency.


Management information

Registered date

2010 Year 04 Month 03 Day

Last modified on

2015 Year 05 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004169


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name